Doctor profile · Federal record

Dr. Jane Ayala, M.D.

Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Internal Medicine Physician · San Antonio, TX

  • NPI 1093914681
  • Accepts Medicare
  • MIPS 94.4 / 100 · 2023
  • 24 yrs in practice
  • Licensed in 2 states
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
19272 Stone Oak Pkwy, Suite 101
San Antonio, TX 782583371
(210) 265-8851
fax (210) 265-8855

Credentials & registration

NPPES · NUCC
NPI registered
July 2007 — 19 yrs on file
Profile last updated
September 22, 2016
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State licenses (2)
Texas #M7836 · Indiana #01064100A

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1093914681. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
125,139
Distinct HCPCS
10
Medicare allowed
$2,147,294
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 44,200 27 $5
J1602 Injection, golimumab, 1 mg, for intravenous use 25,251 53 $13
J3262 Injection, tocilizumab, 1 mg 18,969 11 $6
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 17,700 52 $42
J0897 Injection, denosumab, 1 mg 4,380 55 $23
J1745 Injection, infliximab, excludes biosimilar, 10 mg 3,395 24 $33
J9312 Injection, rituximab, 10 mg 2,714 12 $71
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg 1,720 15 $38
99214 Established patient office or other outpatient visit, 30-39 minutes 876 335 $119
86235 Measurement of antibody for assessment of autoimmune disorder, any method 757 100 $18

In context: peer comparison

Among 14 peers in San Antonio Rheumatology Physician, average services per provider: 2,374. This provider delivers 53× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,647
Transactions
132
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 36 $707.29
Novartis Pharmaceuticals Corporation 16 $359.23
Janssen Biotech, INC. 16 $283.72
Ucb, INC. 10 $280.62
GlaxoSmithKline, LLC. 12 $186.04
AstraZeneca Pharmaceuticals Lp 6 $142.79
Genzyme Corporation 6 $137.83
Genentech USA, INC. 9 $133.61
Pfizer INC. 6 $89.72
Mallinckrodt Hospital Products INC. 5 $80.29
Organon LLC 3 $55.94
Ani Pharmaceuticals, INC. 3 $47.36
Lilly USA, LLC 2 $38.92
Aurinia Pharma U.S., INC. 1 $27.34
E.R. Squibb & Sons, L.L.C. 1 $21.45

By nature of payment

Food and Beverage
$2,647

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,403
Patients
469
Total drug cost
$1,171,992
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 323 122 $22,782
Methotrexate (Methotrexate Sodium) Brand 169 70 $8,647
Duloxetine Hcl Generic 124 41 $4,489
Prednisone Generic 108 54 $803
Gabapentin Generic 94 34 $3,015
Humira(Cf) Pen (Adalimumab) Brand 87 0 $680,428
Leflunomide Generic 75 38 $5,274
Sulfasalazine Generic 74 31 $2,909
Allopurinol Generic 57 16 $887
Folic Acid Generic 55 19 $290

Frequently asked questions

Auto-generated from federal data
What is Dr. Jane Ayala's medical specialty?
Dr. Jane Ayala practices Rheumatology Physician in San Antonio, TX.
Where does Dr. Jane Ayala practice?
Dr. Jane Ayala practices at 19272 Stone Oak Pkwy, San Antonio, TX 782583371. Office phone: 2102658851.
What is Dr. Jane Ayala's NPI?
Dr. Jane Ayala's National Provider Identifier (NPI) is 1093914681, issued by NPPES.
Does Dr. Jane Ayala accept Medicare assignment?
Yes. Dr. Jane Ayala accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jane Ayala commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, tocilizumab, 1 mg (HCPCS J3262). Source: CMS Medicare Physician & Other Practitioners file.